Neuland Laboratories Ltd.

Financial

	Neuland Laboratories	Gufic Biosciences	Alivus Life Sciences
Operational Metrics
API Sector
US DMF Filings	70.0 .	n/a	548.0 .
Global DMFs filed	980.0 .	n/a	n/a
Total reactor capacity	941.0 kL	n/a	n/a
Pharmaceutical Sector
R&D as a % of Total Sales	2.79 %	0.83 %	3.2 %
Financials
5 yr Average ROE	11.99 %	25.05 %	37.41 %
5yr average Equity Multiplier	1.62	2.22	2.33
5yr Average Asset Turnover Ratio	0.72	1.05	0.76
5yr Avg Net Profit Margin	10.09 %	10.9 %	20.19 %
Price to Book	11.79	6.3	4.96
P/E	54.85	44.15	28.5
5yr Avg Cash Conversion Cycle	45.08 Days	26.94 Days	76.63 Days
Inventory Days	89.03 Days	66.86 Days	93.94 Days
Days Receivable	86.1 Days	128.09 Days	125.3 Days
Days Payable	113.14 Days	163.91 Days	114.87 Days
5yr Average Interest Coverage Ratio	12.92	13.1	320.13
5yr Avg ROCE	16.09 %	27.25 %	51.63 %
5yr Avg Operating Profit Margin	19.31 %	18.45 %	30.06 %
5 yr average Debt to Equity	0.21	0.51	0.0
5yr CAGR Net Profit	79.26 %	14.26 %	8.5 %
5yr Average Return on Assets	7.75 %	11.52 %	15.32 %
Shareholdings
Promoter Holding	32.68 %	72.51 %	74.99 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-3.54 %	-2.97 %	-7.86 %
Change in Mutual Fund Holding (3 Yrs)	6.64 %	2.36 %	3.09 %

Business

	Neuland Laboratories	Gufic Biosciences	Alivus Life Sciences
Product Wise Break-Up	Product Wise Break-Up Formulations 56.0 Custom Manufacturing Solutions(CMS) 39.0 API 0 Muscle Relaxants 0 Cardiovascular 0 Proton pump inhibitors 0 Anti-fungals 0 Anti-bacterials 0 International 0 CMO 0 Domestic 0 API`s 0 CDMO 0 Generic API 0 Others 5.0	Product Wise Break-Up API`s 0 Proton pump inhibitors 0 Custom Manufacturing Solutions(CMS) 0 Formulations 0 Generic API 0 CDMO 0 Active Pharmaceutical Ingredient (API) 5.0 Muscle Relaxants 0 Anti-bacterials 0 CMO 30.0 Domestic Pharmaceuticals 50.0 Anti-fungals 0 International 15.0 Cardiovascular 0	Product Wise Break-Up API`s 0 Proton pump inhibitors 0 Custom Manufacturing Solutions(CMS) 0 Formulations 0 Generic API 92.96 CDMO 4.67 API 0 Muscle Relaxants 0 Anti-bacterials 0 CMO 0 Domestic 0 Anti-fungals 0 International 0 Cardiovascular 0 Others 2.37
Location Wise Break-Up	Location Wise Break-Up USA 39.54 Europe 30.51 India 19.51 Rest of the World 10.44 South America 0 Australia 0 North America 0 Asia 0 Africa 0	Location Wise Break-Up Africa 0.72 Australia 0.53 India 89.07 South America 0.23 North America 1.27 Asia Pacific 4.5 USA 0 Rest of the World 0 Europe 3.67 Others 0.01	Location Wise Break-Up Africa 0 Australia 0 India 51.09 South America 0 North America 0 Asia 0 USA 0 Rest of the World 0 Europe 0 Others 48.91
Therapeutic Area Break-Up	Therapeutic Area Break-Up Anti-bacterial 19.72 Antidepressant 11.8 Anticonvulsant 10.46 Pain Management 0 Diabetes 0 CNS 0 CVS 0 Others 58.02	-	Therapeutic Area Break-Up CVS 44.0 Pain Management 4.0 CNS 14.0 Anticonvulsant 0 Antidepressant 0 Anti-bacterial 0 Diabetes 5.0 Others 33.0
Asset Break-Up	Asset Break-Up India 100.0	-	-

Neuland Laboratories Ltd.

SIGN UP FOR FREE